Collaborative efforts between drugmakers and medical food manufacturers to drive growth opportunities

company logo

Dublin, Oct. 28, 2022 (GLOBE NEWSWIRE) — The “Global Medical Food Growth Opportunities” report has been added to from offer.

This study aims to understand the role of a medical food in the healing of patients. It provides qualitative and quantitative analysis of medical food ingredients and finished medical food products.

North America and Europe accounted for the majority of the market share of medical food ingredients and finished medical food products in 2021 owing to growing awareness among physicians and increasing medical adherence among patients. The factors supporting the growth of the market in these regions are the expanding geriatric population, the prevalence of chronic diseases, and the increasing focus by policy makers on the management of malnutrition.

The United States FDA defines a medical food as “a food that is formulated for consumption or enteral administration under the supervision of a physician and is intended for the specific dietary management of a disease or a state for which special nutritional requirements, based on recognized scientific data. principles, are established by medical evaluation.”

Medical foods are interpreted as “foods for special medical purposes (FSMP)” in several countries, including Europe, India, China, Australia and New Zealand. In Japan, medical food is interpreted as “food for the sick”. In Canada, medical foods are governed by the Foods for Special Dietary Use (FSDU) and Infant Foods Regulations.

Globally, the regulatory landscape for medical foods is not clearly defined, even in developed economies. As medical foods are not intended to prevent or treat disease, they are not subject to the same regulatory requirements as pharmaceutical drugs.

By ingredient, the medical food market is split into vitamins and minerals; protein ingredients (animal and vegetable); nutritional lipids; prebiotics; and others (amino acids and probiotics). Among these, protein ingredients held the majority share of 64.0% (2021) in the total medical food ingredients market owing to the significant role they play in healing trauma and disease.

The impact of the COVID-19 pandemic is taken into account in the analysis. The pandemic has brought about both positive and negative changes in the medical food market. Supply chain disruptions due to the closure of processing facilities and other containment measures have affected the sale of ingredients and finished medical foods.

However, the negative effects have been reduced to some extent due to growing consumer awareness and research highlighting the benefits of medical food in patient recovery.

Main characteristics

  • By type, the medical foods market is fragmented into prescription and over-the-counter foods. Prescription medical foods dominated the medical foods market with a share of 60.0% in 2021 due to high demand from developed economies for use in life-threatening health conditions such as oncology health, critical care and trauma, cardiovascular health, diabetes health and cognitive health. Major players in the market, such as Abbott, Nestle Health Science, and Nutricia, offer large portfolios of prescription medical food products to meet growing demand.

  • By mode of administration, the medical nutrition market is categorized into oral tube feeding (food or supplement format) and enteral. Oral mode accounted for the largest market share of 75.0% in 2021. Preference for orally administered products, ease of availability without a prescription, and supportive initiatives are key factors driving the demand for foods orally administered drugs.

  • By application, the medical food market is segmented into malnutrition (including oncology health, immune health, and general malnutrition); metabolic health; digestive health; intensive care and traumatology; diabetes health; cardiovascular health; musculoskeletal health; and cognitive and central nervous system (CNS) health. Malnutrition, metabolic disorders, digestive disorders, intensive care and trauma are the main diseases targeted by medical foods. Brain and cognitive health remains a small segment; nevertheless, it is one of the fastest growing application areas of medical power.

Main topics covered:

1. Strategic imperatives

  • Why is it increasingly difficult to grow taller?

  • The strategic imperative

  • The Impact of the Top 3 Strategic Imperatives on the Medical Food Industry

  • Growth opportunities fuel the growth pipeline engine

2. Analysis of growth opportunities

  • Scope of analysis

  • Medical food – Definition

  • Differences between dietary supplements, medical foods and pharmaceutical drugs

  • Segmentation

  • Definition by type of ingredient

  • Definition by type and mode of administration

  • Definition by application

  • Key competitors

  • Value chain

  • Growth engines

  • Growth constraints

  • Forecast assumptions

  • Impact of the COVID-19 pandemic on the medical food market

  • COVID-19 – Induced Research

  • COVID-19 – Induced market trends

  • Regulatory landscape

  • Insurance Coverage and Reimbursement Scenario

3. Growth Opportunities Analysis – Medical Food Ingredients

  • Growth indicators

  • Role of Ingredients in Patient Recovery – Protein Ingredients

  • Role of Ingredients in Patient Recovery – Nutritional Lipids

  • Role of Ingredients in Patient Recovery – Prebiotics

  • Role of Ingredients in Patient Recovery – Vitamins and Minerals

  • Ingredient Trends

  • Revenue forecast

  • Revenue forecast by ingredient

  • Revenue Forecast Analysis by Ingredients

  • Revenue forecasts by region

  • Revenue forecast analysis by region

  • Competitive environment

  • Competitor Product Matrix

  • Product Launches – Medical Food Ingredients: 2021 and 2022

  • Product Launches – Medical Food Ingredients: 2021

  • Product Launches – Medical Food Ingredients: 2020 and 2022

  • Product Launches – Medical Food Ingredients: 2019 and 2020

4. Growth Opportunity Analysis – Finished Medical Food Products

  • Growth indicators

  • Prescription Medical Foods – Examples

  • Non-Prescription Medical Foods – Examples

  • Role of medical foods in the state of malnutrition

  • Role of Medical Foods in Metabolic Health

  • Role of medical food in digestive health

  • Role of medical food in critical care and trauma

  • Role of medical nutrition in musculoskeletal health

  • Role of medical foods in cognitive and CNS health

  • Role of medical diet in diabetes health

  • Role of medical food in cardiovascular health

  • Revenue forecast

  • Revenue forecast analysis

  • Revenue forecast by type

  • Revenue forecast analysis by type

  • Revenue forecasts by mode of administration

  • Analysis of revenue forecasts by mode of administration

  • Revenue forecasts by region

  • Revenue forecast analysis by region

  • Revenue percentage by application and market penetration

  • Competitive environment

  • Revenue sharing

  • Recent acquisitions – 2019-2022

  • Recent Product Launches – 2019, 2020 and 2021

5. Universe of growth opportunities

  • Growth Opportunity 1: Collaborative Efforts Between Drug Manufacturers and Medical Food Manufacturers

  • Growth Opportunity 2: Promotional Activities and Wide Reimbursement Coverage

  • Growth Opportunity 3: Increased focus of research on the design of specific ingredients for medical food applications

  • Growth Opportunity 4: Innovation in Functional Ingredients

6. Next steps

Companies cited

  • Abbott

  • Nestlé Health Sciences

  • nutricia

For more information on this report, visit

CONTACT: CONTACT: Laura Wood,Senior Press Manager For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

Comments are closed.